2021 Scientific Sessions

Insights and Implications on Reduction of Ischemic Events With Eicosapentaenoic Acid

This activity is supported by an unrestricted educational grant from Amarin Pharma, Inc.
Welcome and Opening Remarks
C. Michael Gibson, M.D., MSCAI, Beth Israel Deaconess Medical Center, Natick, MA
Cardiovascular Outcomes Trials of Omega-3 Fatty Acids in ASCVD
Deepak L. Bhatt, M.D., M.P.H., MSCAI, Mount Sinai Health System, Scarsdale, NY
See more of: Satellite Sessions